AC Immune SA
ACIU · Pharmaceutical Preparations
Latest available SEC filing: 3/A ·
Latest disclosures
-
Graney Thomas: Form 3/A
Insider disclosure · Filed · Report period 02 Oct 2026
-
Form 3
SEC filing · Filed
-
Form 3/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ACIU · H00263105 - SHS
Company details and SEC sources
CIK 0001651625 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ACIU on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Epfl Innovation Park, Building B, 1015 Lausanne, Switzerland, 00000
- Incorporated in
- Switzerland
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields